Dysregulation of IL‐2 and IL‐8 production in circulating T lymphocytes from young cystic fibrosis patients

Cédric Hubeau,R. L. Naour,M. Abély,J. Hinnrasky,M. Guenounou,Dominique Gaillard,Edith Puchelle

DOI: https://doi.org/10.1111/j.1365-2249.2003.02385.x

2004-03-01

Abstract:It is well documented that patients with cystic fibrosis (CF) are unable to clear persistent airway infections in spite of strong local inflammation, suggesting a dysregulation of immunity in CF. We and others have reported previously that T lymphocytes may play a prominent role in this immune imbalance. In the present work, we compared the reactivity of CD3+ T cells obtained from young CF patients in stable clinical conditions (n = 10, aged 9–16·5 years) to age‐matched healthy subjects (n = 6, aged 9–13·5 years). Intracellular levels of interferon (IFN)‐γ, interleukin (IL)‐2, IL‐8 and IL‐10 were determined by flow cytometry after whole blood culture. The data identified T lymphocyte subsets producing either low levels (M1) or high levels (M2) of cytokine under steady‐state conditions. We found that the production of IFN‐γ and IL‐10 by T lymphocytes was similar between young CF patients and healthy subjects. In contrast, after 4 h of activation with PMA and ionomycin, the percentage of T cells producing high levels of IL‐2 (M2) was greater in CF patients (P = 0·02). Moreover, T cells from CF patients produced lower levels of IL‐8, before and after activation (P = 0·007). We conclude that a systemic immune imbalance is present in young CF patients, even when clinically stable. This disorder is characterized by the capability of circulating T lymphocytes to produce low levels of IL‐8 and by the emergence of more numerous T cells producing high levels of IL‐2. This imbalance may contribute to immune dysregulation in CF.